With Data Coming Slowly On Cannabis, Hemp Ingredients, FDA Launches ‘Acceleration Plan’

Cannabis-Derived Products Data Acceleration Plan aims to avoid same conclusion already found in FDA's more-than two-year search for information on using cannabis ingredients in supplements, food and beverages and personal care topicals: too little is available to determine safety.

The US Food and Drug Administration reveals it holds out hope for establishing lawful use of hemp ingredients in non-drug products subject to its regulatory oversight by launching another program intended to gather data.

The Cannabis-Derived Products Data Acceleration Plan launched in October, however, could reach the same conclusion the agency has found in...